Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-02-11 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 4 - Statement of Changes in Beneficial Ownership 2 pages 13.7KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC), which reports changes in beneficial ownership of company securities by insiders such as directors and officers. It includes detailed tables of stock transactions by Michael J. Farrell, the CEO of ResMed Inc., including dates, transaction codes, amounts, and prices. Form 4 is specifically used to disclose insider trading activities and personal share transactions by company executives or directors. This matches the definition of 'Director's Dealing' filings. The document is not a financial report, earnings release, or any other type of corporate filing but a regulatory insider transaction report.
2025-02-11 English
Form 4 - Statement of Changes in Beneficial Ownership 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which reports changes in beneficial ownership of company securities by insiders such as officers or directors. It includes details of securities acquired or disposed of by Brett Sandercock, the Chief Financial Officer of ResMed Inc. This type of filing is specifically related to insider transactions and personal share dealings by company executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification.
2025-02-11 English
Notice of Proposed Sale of Securities 3 pages 116.4KB
Regulatory Filings Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It contains detailed information about the filer, issuer, securities to be sold, acquisition details, and sales in the past 3 months. This type of filing is related to insider or affiliate sales of securities and is not a financial report, earnings release, or management discussion. It is a regulatory filing notifying the SEC and the public about the intended sale of restricted or control securities. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other specific categories.
2025-02-10 English
Form 144 - Notice of Proposed Sale of Securities 2 pages 111.1KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including the number of shares, dates, and broker information. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not a financial report, earnings release, or any other type of corporate report. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 4385 characters, which is consistent with a detailed insider transaction report rather than a brief announcement or a full report. Confidence is high due to the clear identification of Form 144 and the nature of the content.
2025-02-09 English
Statement of changes in beneficial ownership of securities 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by directors, officers, or significant shareholders. The text includes details of a transaction by Peter C. Farrell, a director and 10% owner, involving ResMed Inc. It reports the sale of shares and derivative securities. This type of filing is specifically related to insider transactions by company directors or executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification.
2025-02-05 English
NOTICE OF PROPOSED SALE OF SECURITIES 3 pages 120.8KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider (a director) including dates, amounts, and broker information. This type of filing is specifically related to insider transactions of securities, not a financial report, earnings release, or management announcement. It matches the description of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4711 characters, which is consistent with a detailed insider transaction report. Therefore, the correct classification is Director's Dealing (DIRS).
2025-02-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.